Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-006930
Filing Date
2021-06-15
Accepted
2021-06-15 16:34:34
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 section16.html 4  
1 FORM 4 section16.xml 4 3455
  Complete submission text file 0001654954-21-006930.txt   5179
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC. 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 211018935